Noah (NYSE:NOAH – Get Free Report)‘s stock had its “neutral” rating reiterated by research analysts at JPMorgan Chase & Co. in a research report issued on Wednesday, Marketbeat.com reports.
AZoRobotics on MSN10d
Noah Medical’s Galaxy System Surpasses 5,000 Procedures, Marking a New Era in Robotic-Assisted BronchoscopyMilestone highlights rapid adoption of the Galaxy System’s advanced image-guided technology, transforming lung nodule diagnosis and patient careSAN CARLOS, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback